Fredrik Jäderling

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: EUROPEAN RADIOLOGY. 2026;36(8):6476-6486
Ongoing and completed clinical trials on prostate cancer screening using MRI
Wallstrom J; Jaderling F; Langkilde F; Arnsrud Godtman R; Bratt O; Thimansson E
Article: EUROPEAN RADIOLOGY. 2026;36(7):5728-5744
Prostate MRI quality improvement: a Roadmap from the ESUR Prostate MRI Working Group
Dias AB; Barentsz J; Allen C; Baroni RH; Falinska H; Gaudiano C; Girometti R; Gupta RT; Jaderling F; Junker D; Kukuk GM; Moreira ASL; Logager V; Puech P; Purysko AS; Uhlig J; Ursprung S; Villeirs G; Richenberg J; Giganti F
Journal article: ACTA ONCOLOGICA. 2026;65:375-378
SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer.
Welén K; Josefsson A; SPRINTR study group
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2026;87:48-56
Trends and Patterns in Prostate Cancer Diagnostics During the Era of MRI Implementation - Real-world Evidence From a Population-based Study in the Stockholm Region, Sweden 2010-2023
Engel JC; Rai B; Eklund M; Jaderling F; Clements M; Nordstrom T
Journal article: JOURNAL OF UROLOGY. 2026;215(5S):e1524
VALUE OF STOCKHOLM3 IN MEN WITH PSA 1.5-3 NG/ML: EVIDENCE FROM THE SWEDISH PROSTATE CANCER REGISTRY
Micoli C; Abbadi A; Soderback H; Jaderling F; Bergman M; Eklund M; Tilki D; Gronberg H; Nordstrom T; Palsdottir T; Vigneswaran H
Journal article: RADIOLOGY: IMAGING CANCER. 2026;8(3):e250461
Evaluating an AI-driven Triaging Workflow for MRI-based Clinically Significant Prostate Cancer Diagnosis: A Simulation Study.
Twilt JJ; Saha A; Bosma JS; Giannarini G; Padhani AR; Yakar D; Elschot M; Veltman J; Fütterer J; Huisman H; de Rooij M; PI-CAI Consortium
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2026;61:64-71
Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results
Ventimiglia E; Gedeborg R; Westerberg M; Zaurito P; Jaderling F; Stattin P; Garmo H
Article: EUROPEAN UROLOGY ONCOLOGY. 2025;8(6):1466-1473
Repeat Prostate Cancer Screening using Blood-based Risk Prediction or Prostate-specific Antigen in the Era of Magnetic Resonance Imaging-guided Biopsies : A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial
Discacciati A; Abbadi A; Clements MS; Annerstedt M; Carlsson S; Gronberg H; Jaderling F; Eklund M; Nordstrom T
Article: INSIGHTS INTO IMAGING. 2025;16(1):261
Incidental findings on prostate MRI in a population-based screening setting
Huang V; Dang H; Thimansson E; Jiborn T; Jaderling F; Lantz A; Godtman RA; Wallstrom J; Bratt O
Article: EUROPEAN UROLOGY FOCUS. 2025;11(6):855-862
Prostate-specific Antigen Density as a Selection Tool Before Magnetic Resonance Imaging in Prostate Cancer Screening: An Analysis from the STHLM3MRI Randomized Clinical Trial
Bjornebo L; Discacciati A; Abbadi A; Falagario UG; Engel JC; Vigneswaran HT; Jaderling F; Gronberg H; Eklund M; Lantz A; Nordstrom T
Article: EJNMMI RESEARCH. 2025;15(1):127
The impact of short-term non-steroidal androgen antagonist therapy on PSMA expression and tumor cellularity studied with dynamic [⁶⁸Ga]Ga-PSMA-11 PET/MR in hormone-sensitive prostate cancer patients, a preliminary longitudinal prospective study
Sanchez-Crespo A; Jonmarker O; Jaderling F; Carlsson S; Olsson M; Li C; Axelsson R
Journal article: JAMA NETWORK OPEN. 2025;8(6):e2515672
AI-Assisted vs Unassisted Identification of Prostate Cancer in Magnetic Resonance Images.
Twilt JJ; Saha A; Bosma JS; Padhani AR; Bonekamp D; Giannarini G; van den Bergh R; Kasivisvanathan V; Obuchowski N; Yakar D; Elschot M; Veltman J; Fütterer J; Huisman H; de Rooij M; PI-CAI Consortium
Article: EUROPEAN JOURNAL OF RADIOLOGY OPEN. 2025;14:100625
An online national quality assessment survey of prostate MRI reading: interreader variability in prostate volume measurement and PI-RADS classification
Wallstrom J; Thimansson E; Andersson J; Karlsson M; Zackrisson S; Bratt O; Jaderling F
Article: ECLINICALMEDICINE. 2025;82:103191
Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort study
Abbadi A; Eklund M; Lantz A; Discacciati A; Bjornebo L; Palsdottir T; Engel JC; Jaderling F; Falagario U; Gronberg H; Nordstrom T
Journal article: ECLINICALMEDICINE. 2025;82:103191
Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort study.
Abbadi A; Eklund M; Lantz A; Discacciati A; Björnebo L; Palsdottir T; Chandra Engel J; Jäderling F; Falagario U; Grönberg H; Nordström T
Article: EUROPEAN UROLOGY ONCOLOGY. 2025;8(2):435-443
Diagnostic Effects of Omitting Systematic Biopsies in Prostate Cancer Screening
Engel JC; Eklund M; Jaderling F; Palsdottir T; Falagario U; Discacciati A; Nordstrom T
Article: BJU INTERNATIONAL. 2025;135(2):245-248
A novel approach to integrated prostate cancer diagnostics: insights from MRI, prostate biopsy, and pathology reports in a pilot study
Thimansson E; Axen E; Jaderling F; Styrke J; Nyberg M; Hageman N; Ivarsson J; Malmberg G; Gaspar V; Tornblom M
Journal article: EUROPEAN UROLOGY. 2025;87(2):240-250
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer: An International, Paired, Noninferiority, Confirmatory Observer Study.
Twilt JJ; Saha A; Bosma JS; van Ginneken B; Bjartell A; Padhani AR; Bonekamp D; Villeirs G; Salomon G; Giannarini G; Kalpathy-Cramer J; Barentsz J; Maier-Hein KH; Rusu M; Rouvière O; van den Bergh R; Panebianco V; Kasivisvanathan V; Obuchowski NA; Yakar D; Elschot M; Veltman J; Fütterer JJ; Huisman H; de Rooij M; PI-CAI Consortium / list of collaborators
Article: ACTA ONCOLOGICA. 2024;63:816-821
A pilot study of AI-assisted reading of prostate MRI in Organized Prostate Cancer Testing
Thimansson E; Zackrisson S; Jaderling F; Alterbeck M; Jiborn T; Bjartell A; Wallstrom J
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2024;67:s14
PE012 Can we rely solely on MRI/targeted biopsies and excluding systematic biopsies preoperatively in radical prostatectomy?
Hagman A; Pellegrino F; Egevad L; Jäderling FJ; Falagario U; Proietti F; Brasetti A; Lantz A; Wiklund P
Visa fler

Alla övriga publikationer

Review: EUROPEAN RADIOLOGY. 2026;36(7):5745-5754
ESR Essentials: MRI-based T-staging in prostate cancer-practice recommendations by the European Society of Urogenital Radiology
Agrotis G; Jaderling F; Lakhani A; Moreira ASL; Kekelidze M; Rembak-Szynkiewicz J; Logager V; Thoeny H; Villeirs G; Woo S; Schoots IG
Review: EUROPEAN JOURNAL OF RADIOLOGY. 2025;191:112363
Radiological T-staging in prostate Cancer: Towards a universal MRI-based scoring system
Agrotis G; Woo S; Jaderling F; Ursprung S; Withey SJ; Purysko AS; Barrett T; Villeirs G; Schoots IG
Book chapter: CANCER PREVENTION, DETECTION, AND INTERVENTION: LECTURE NOTES IN COMPUTER SCIENCE. 2025;p. 73-82
On Undesired Emergent Behaviors in Compound Prostate Cancer Detection Systems
Sortland Rolfsnes E; Thangngat P; Eftestøl T; Nordström T; Jäderling F; Eklund M; Fernandez-Quilez A
Corrigendum: EUROPEAN UROLOGY. 2022;82(1):e21
Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study (vol 82, pg 12, 2022)
Hao S; Heintz E; Ostensson E; Discacciati A; Jaderling F; Gronberg H; Eklund M; Nordstrom T; Clements MS
Editorial: JOURNAL OF UROLOGY. 2022;207(1):231
Re: MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
Conference publication: EUROPEAN UROLOGY. 2021;79:S1429
Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, magnetic resonance imaging and targeted prostate biopsies: The STHLM3MRI trial
Nordstrom T; Discacciati A; Bergman M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jaderling F; Eklund M; Gronberg H
Conference publication: EUROPEAN UROLOGY. 2021;79:S1430
MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial
Eklund M; Jaderling F; Discacciati A; Bergman M; Annerstedt M; Aly M; Glaessgen A; Carlsson S; Gronberg H; Nordstrom T
Preprint: MEDRXIV. 2021
Cost-effectiveness of Stockholm3 test and magnetic resonance imaging in prostate cancer screening: a microsimulation study
Hao S; Heintz E; Östensson E; Discacciati A; Jäderling F; Grönberg H; Eklund M; Nordström T; Clements M
Preprint: SSRN ELECTRONIC JOURNAL. 2021
Prostate Cancer Screening Using a Combination of Risk-Prediction, Magnetic Resonance Imaging and Targeted Prostate Biopsies: A Randomised Trial
Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6)
Incorporating mpMRI and biomarkers in active surveillance protocols: The prospective Stockholm3 Active Surveillance trial (STHLM3AS)
Lantz A; Olsson H; Nordstrom T; Jaderling F; Egevad L; Annerstedt M; Gronberg H; Eklund M
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(6)
MRI-targeted biopsies in prostate cancer screening and the value of its combination with blood-based risk-prediction: The randomized, diagnostic study STHLM3MRI
Nordstrom T; Discacciati A; Jaderling F; Karlsson SG; Aly M; Gronberg H; Eklund M
Study protocol: BMJ OPEN. 2019;9(8):e027860
PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design
Ahlberg MS; Adami H-O; Beckmann K; Bertilsson H; Bratt O; Cahill D; Egevad L; Garmo H; Holmberg L; Johansson E; Rannikko A; Van Hemelrijck M; Jaderling F; Wassberg C; Aberg UWN; Bill-Axelson A
Study protocol: BMJ OPEN. 2019;9(6):e027816
Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
Nordstrom T; Jaderling F; Carlsson S; Aly M; Gronberg H; Eklund M
Conference publication: SCANDINAVIAN JOURNAL OF UROLOGY. 2019;53:40
Improved prostate cancer diagnostics with a structured pathway including the Stockholm3 test and MRI-targeted biopsies led by nurses
Thorstenson A; Melander-Bergstrom C; Cavalli-Bjorkman C; Bergman M; Hjelm-Eriksson M; Jaderling F; Meurling E; Nordstrom T; Gronberg H
Study protocol: SCANDINAVIAN JOURNAL OF UROLOGY. 2018;52(5-6):313-320
SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
Stranne J; Brasso K; Brennhovd B; Johansson E; Jaderling F; Kouri M; Lilleby W; Petersen PM; Mirtti T; Pettersson A; Rannikko A; Thellenberg C; Akre O
Study protocol: EUROPEAN UROLOGY FOCUS. 2017;3(6):526-528
Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project
Nordstrom T; Picker W; Aly M; Jaderling F; Adolfsson J; Strom P; Haug ES; Eklund M; Carlsson S; Gronberg H
Corrigendum: ONCOLOGY LETTERS. 2017;13(6):5035
Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis (vol 12, pg 1293, 2016)
Holmsten K; Dohn L; Jensen NV; Shah C-H; Jaderling F; Pappot H; Ullen A
Doctoral thesis: 2016
Preoperative local staging of prostate cancer : aspects on predictive models, magnetic resonance imaging and interdisciplinary teamwork
Jäderling F
Conference publication: SCANDINAVIAN JOURNAL OF UROLOGY. 2013;47:30-31
Diagnostic accuracy of ct and ureteroscopy in urothelial carcinoma of the upper urinary tract
Grahn A; Melle-Hannah M; Malm C; Jaderling F; Radecka EE; Beckman M; Brehmer M

Forskningsbidrag

Artificial intelligence for reproducible MRI diagnosis of prostate cancer
Swedish Research Council
1 januari 2021 - 31 december 2023
SPCG-15: SURGERY VERSUS RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER: A RANDOMIZED CLINICAL TRIAL.
Swedish Research Council
1 december 2017 - 31 december 2018

Anställningar

Anknuten till Forskning, Molekylär medicin och kirurgi, Karolinska Institutet, 2026-2029

Examina och utbildning

Docent, radiologi och bildbehandling, Karolinska Institutet, 2025
Medicine Doktorsexamen, Institutionen för molekylär medicin och kirurgi, Karolinska Institutet, 2017
Läkarexamen, Karolinska Institutet, 1997

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI